Innovative Wound Dressings for Diabetic Foot Treatment

OpenAlex İngilizce

Diabetes-related foot ulcers lead to increased morbidity, death, and economic consequences.nDiabetes-related foot disorders lead to about 1 million partial limb amputations each year. Every 20nseconds, a limb is lost somewhere in the world.nTheirnpathophysiology encompasses neuropathy, trauma, infection, and vascular blockage, which impair wound healing. Wound healing methodologies can be classified into conventional care interventions and advanced therapeutic approaches. Standard treatments, including debridement, offloading, and infection control, are employed in conjunction with sophisticated therapies such as negative pressure wound therapy, hyperbaric oxygen therapy, and growth factor applications. New wound dressings are being developed to help diabetic foot ulcers (DFUs) heal more quickly. These dressings provide multiple advantages, including antibacterial characteristics, enhanced mois ture retention, and expedited tissue regeneration. The following have demonstrated superior healing outcomes in DFUs: human amniotic membrane, LeucoPatch, resveratrol, bioengineered skin substi tutes, microRNA-based wound dressings, and fish skin grafts. These solutions are practical and suit able for complex cases. These improvements show potential for enhancing diabetic foot ulcer treatment; however, additional data is necessary to validate their long-term efficacy and cost-effectiveness. Innovative wound dress ings should be regarded as supplementary to the optimal standard of care when the standard treat ment alone has proven ineffective in healing the ulcers. Despite international diabetic foot guidelines categorizing these goods as weak recommendations supported by low to moderate evidence, there remains a continual necessity for novel strategies. These developments can substantially augment the management of DFUs by supplementing and refining current therapeutic modalities. Cite this article as: Çetinkalp Ş. Innovative wound dressings for diabetic foot treatment. Endocrinol Res Pract. 2025;29(2):128-132.